Title | Associations Between Left Ventricular Structure, Function, and Cerebral Amyloid: The ARIC-PET Study. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Johansen MC, Mosley TH, Knopman DS, Wong DF, Wagenknecht LE, Shah AM, Solomon SD |
Secondary Authors | Gottesman RF |
Journal | Stroke |
Volume | 50 |
Issue | 12 |
Pagination | 3622-3624 |
Date Published | 2019 12 |
ISSN | 1524-4628 |
Keywords | Aged, Aged, 80 and over, Amyloid beta-Peptides, Aniline Compounds, Brain, Echocardiography, Ethylene Glycols, Female, Fluorine Radioisotopes, Heart Ventricles, Humans, Logistic Models, Male, Multivariate Analysis, Odds Ratio, Organ Size, Positron-Emission Tomography, Ventricular Function, Left |
Abstract | Background and Purpose- Cardiovascular disease is a known risk factor for cognitive decline, although the mechanisms remain unclear. We hypothesize that Aβ (β-amyloid), a core pathology of Alzheimer's disease, will be associated with subclinical cardiac structure and function echocardiogram indices. Methods- Three hundred six nondemented participants from the ARIC study (Atherosclerosis Risk in Communities Study) underwent florbetapir positron emission tomography and 2D echocardiography (echo). Cross-sectional associations between echo markers of left ventricular structure and function and global cortical Aβ (≥1.2 standardized uptake value ratio were evaluated using multivariable logistic regression with interaction terms when appropriate. Results- Participants ranged in age from 67 to 88 years, were 57% female and 42% black. Per 1 cm increase in end-diastolic left ventricular diameter, the odds of elevated florbetapir standardized uptake value ratio doubled (odds ratio, 2.04 [95% CI, 1.10-3.77]), with similar findings when excluding mild cognitive impairment (odds ratio, 2.61 [95% CI, 1.22-5.59]). Conclusions- We have demonstrated a significant association between a marker of left ventricular structure and elevated florbetapir standardized uptake value ratio, identified using positron emission tomography. Ongoing prospective work will help determine if changes in cardiac structure and function either precede, or occur simultaneously with deposition of amyloid. |
DOI | 10.1161/STROKEAHA.119.027220 |
Alternate Journal | Stroke |
PubMed ID | 31597548 |
PubMed Central ID | PMC6878182 |
Grant List | U01 HL096812 / HL / NHLBI NIH HHS / United States R01 AG040282 / AG / NIA NIH HHS / United States HHSN268201700001I / HL / NHLBI NIH HHS / United States HHSN268201700004I / HL / NHLBI NIH HHS / United States HHSN268201700003I / HL / NHLBI NIH HHS / United States K24 AG052573 / AG / NIA NIH HHS / United States HHSN268201700002I / HL / NHLBI NIH HHS / United States HHSN268201700005I / HL / NHLBI NIH HHS / United States |